Skip to content

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle

Effects of Novel SCS Paddle on Intraoperative Neuromonitoring Recording

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05045625
Enrollment
12
Registered
2021-09-16
Start date
2020-01-10
Completion date
2021-03-20
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Complex Regional Pain Syndromes, Failed Back Surgery Syndrome, Neuropathic Pain

Keywords

Spinal cord stimulation, chronic pain

Brief summary

The purpose of this study is to demonstrate safety and efficacy of a new spinal cord stimulation paddle electrode which is able to target the dorsal horns, dorsal nerve roots, and dorsal columns. The research electrode (Study Electrode) is designed to answer basic physiological clinical research questions. It may inform future device therapy development, but the Study Electrode is not a product that will be marketed or sold. The Investigators believe the protocol is a Non-Significant Risk study answering basic physiological research questions, which may be performed under hospital IRB approval.

Interventions

The HD Study Electrode is an array of 8 columns of stimulation contacts arranged in 8 rows with a low-volume electrode body. This array of stimulation electrodes contact patterns of bi-poles and tri-poles may be applied to the spinal cord for assessment of dermatomal selective stimulation patterns.

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing a spinal cord stimulation procedure for neuropathic pain * must be fluent in English as well as mentally competent to read and answer the questionnaires, as well as complete pain assessment exams. * subjects must be able to give informed consent.

Exclusion criteria

* patients who are not undergoing thoracic spinal cord stimulation for chronic neuropathic pain

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale (NRS)3 monthsPatients rate their pain on a scale from 0-10; 0 being not in pain and 10 being worst pain imaginable. A higher score indicates worse outcome.

Secondary

MeasureTime frameDescription
McGill Pain Questionnaire (MPQ)3 monthPatients select words that describe their pain. There are a total of 15 words. A higher score (more words selected) indicates worse outcome with a range from 0-15.
Oswestry Disability Index (ODI)3 monthsThis is a multiple choice style scale where patients are presented with an activity and asked to select a description which best matches their ability to perform that activity. Multiple choice options are then scored on a scale from 0-5; where 0 is no issues performing the activity and 5 is cannot perform activity. A higher score indicates worse outcome. The range in scores is from 0-100.
Pain Catastrophizing Scale (PCS)3 monthsPatients are presented with a series of statements and they are asked to rate on a scale from 0-4, how often these statements apply to them when they are in pain. 0= never and 4= always. A higher score indicates worse outcome. Scores range from 0-52.
Beck Depression Index (BDI)3 monthsThis is a multiple choice style scale where patients are asked to select a statement related to a feeling of sadness or a component of depression. Multiple choice options are then scored on a scale from 0-3; where 0 is they do not feel that way and 3 is they do feel that way. A higher score indicates worse outcome. Scores range from 0-63

Countries

United States

Participant flow

Participants by arm

ArmCount
Study Group
Twelve patients offered SCS for standard of care were also invited to participate in this study, in which a study electrode was temporarily placed intraoperatively and neuromonitoring was done per our routine standard-of-care HD Study Electrode: The HD Study Electrode is an array of 8 columns of stimulation contacts arranged in 8 rows with a low-volume electrode body. This array of stimulation electrodes contact patterns of bi-poles and tri-poles may be applied to the spinal cord for assessment of dermatomal selective stimulation patterns.
12
Total12

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up3

Baseline characteristics

CharacteristicStudy Group
Age, Continuous52.75 years
STANDARD_DEVIATION 14.75
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
12 Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
1 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Numeric Rating Scale (NRS)

Patients rate their pain on a scale from 0-10; 0 being not in pain and 10 being worst pain imaginable. A higher score indicates worse outcome.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Study GroupNumeric Rating Scale (NRS)5.333333333 score on a scaleStandard Deviation 2.115700942
Secondary

Beck Depression Index (BDI)

This is a multiple choice style scale where patients are asked to select a statement related to a feeling of sadness or a component of depression. Multiple choice options are then scored on a scale from 0-3; where 0 is they do not feel that way and 3 is they do feel that way. A higher score indicates worse outcome. Scores range from 0-63

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Study GroupBeck Depression Index (BDI)14.33333333 units on a scaleStandard Deviation 12.35198075
Secondary

McGill Pain Questionnaire (MPQ)

Patients select words that describe their pain. There are a total of 15 words. A higher score (more words selected) indicates worse outcome with a range from 0-15.

Time frame: 3 month

ArmMeasureValue (MEAN)Dispersion
Study GroupMcGill Pain Questionnaire (MPQ)8.222222222 score on a scaleStandard Deviation 2.886751346
Secondary

Oswestry Disability Index (ODI)

This is a multiple choice style scale where patients are presented with an activity and asked to select a description which best matches their ability to perform that activity. Multiple choice options are then scored on a scale from 0-5; where 0 is no issues performing the activity and 5 is cannot perform activity. A higher score indicates worse outcome. The range in scores is from 0-100.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Study GroupOswestry Disability Index (ODI)50 units on a scaleStandard Deviation 17.13086882
Secondary

Pain Catastrophizing Scale (PCS)

Patients are presented with a series of statements and they are asked to rate on a scale from 0-4, how often these statements apply to them when they are in pain. 0= never and 4= always. A higher score indicates worse outcome. Scores range from 0-52.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Study GroupPain Catastrophizing Scale (PCS)18 units on a scaleStandard Deviation 12.43267584

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026